Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Applied Dna Scns
(NQ:
APDN
)
0.1550
-0.0033 (-2.08%)
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Applied Dna Scns
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 24, 2024
We are starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to read about this morning!
Via
InvestorPlace
Applied DNA Announces 1-For-20 Reverse Stock Split
April 22, 2024
Via
ACCESSWIRE
The Top 5 Analysts Ranked by Marketbeat and Stocks They Cover
April 09, 2024
Analysts rate the stocks, but who rates the analysts? This is a look at five of the highest-rated analysts tracked by Marketbeat.com based on 12-month ROI.
Via
MarketBeat
Topics
Cannabis
Exposures
Cannabis
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 20, 2024
Via
Benzinga
Recap: Applied DNA Sciences Q1 Earnings
February 08, 2024
Via
Benzinga
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
February 08, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 18, 2024
Via
Benzinga
Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start
March 18, 2024
Via
ACCESSWIRE
Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress
March 14, 2024
Via
ACCESSWIRE
Earnings Scheduled For February 8, 2024
February 08, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
Via
Benzinga
Earnings Preview For Applied DNA Sciences
February 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
February 05, 2024
Via
Benzinga
Applied DNA Sciences: Q4 Earnings Insights
December 07, 2023
Via
Benzinga
Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results
December 07, 2023
Via
ACCESSWIRE
Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
November 16, 2023
Via
ACCESSWIRE
Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024
February 05, 2024
Via
ACCESSWIRE
Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
February 02, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 31, 2024
Via
Benzinga
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 31, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 18, 2023
Via
Benzinga
Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform
November 09, 2023
Via
ACCESSWIRE
Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
December 14, 2023
Via
ACCESSWIRE
Lululemon To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Friday
December 08, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
APDN Stock Earnings: Applied DNA Sciences Beats EPS, Misses Revenue for Q4 2023
December 07, 2023
APDN stock results show that Applied DNA Sciences beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via
InvestorPlace
Earnings Scheduled For December 7, 2023
December 07, 2023
Companies Reporting Before The Bell • IES Hldgs (NASDAQ:IESC) is expected to report earnings for its fourth quarter.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 06, 2023
Via
Benzinga
Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023
December 05, 2023
Via
ACCESSWIRE
Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
November 28, 2023
Via
ACCESSWIRE
Applied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals
September 14, 2023
Via
ACCESSWIRE
Applied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs
September 06, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
